Oxidative Damage Compromises Energy Metabolism in the Axonal Degeneration Mouse Model of X-Adrenoleukodystrophy
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
AIMS: Chronic metabolic impairment and oxidative stress are associated with the pathogenesis of axonal dysfunction in a growing number of neurodegenerative conditions. To investigate the intertwining of both noxious factors, we have chosen the mouse model of adrenoleukodystrophy (X-ALD), which exhibits axonal degeneration in spinal cords and motor disability. The disease is caused by loss of function of the ABCD1 transporter, involved in the import and degradation of very long-chain fatty acids (VLCFA) in peroxisomes. Oxidative stress due to VLCFA excess appears early in the neurodegenerative cascade. RESULTS: In this study, we demonstrate by redox proteomics that oxidative damage to proteins specifically affects five key enzymes of glycolysis and TCA (Tricarboxylic acid) cycle in spinal cords of Abcd1(-) mice and pyruvate kinase in human X-ALD fibroblasts. We also show that NADH and ATP levels are significantly diminished in these samples, together with decrease of pyruvate kinase activities and GSH levels, and increase of NADPH. INNOVATION: Treating Abcd1(-) mice with the antioxidants N-acetylcysteine and α-lipoic acid (LA) prevents protein oxidation; preserves NADH, NADPH, ATP, and GSH levels; and normalizes pyruvate kinase activity, which implies that oxidative stress provoked by VLCFA results in bioenergetic dysfunction, at a presymptomatic stage. CONCLUSION: Our results provide mechanistic insight into the beneficial effects of antioxidants and enhance the rationale for translation into clinical trials for X-adrenoleukodystrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ying, W. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1672 · Cited by 1,494 · cited 2×
“, a decrease in cellular reducing potential), which is a powerful regulator of glycolysis, TCA cycle, and oxidative phosphorylation (69) and also in reduced levels of ATP (16, 23).”
Yao, J., Irwin, R. W., Zhao, L., Nilsen, J., Hamilton, R. T., & Brinton, R. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903563106 · Cited by 940 · cited 1×
“According to the findings in a mouse model of AD, glycolysis induction could be a mechanism to compensate for mitochondria dysfunction as a metabolic reprogramming (68).”
Moser, H. W., Mahmood, A., & Raymond, G. V. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0421 · Cited by 663
N -acetylcysteine for antioxidant therapy: pharmacology and clinical utility
Dodd, S., Dean, O., Copolov, D. L., Malhi, G. S., & Berk, M. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14728220802517901 · Cited by 413
Regulation of Oligodendrocyte Development and Myelination by Glucose and Lactate
Rinholm, J. E., Hamilton, N. B., Kessaris, N., Richardson, W. D., Bergersen, L. H., & Attwell, D. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3516-10.2011 · Cited by 383
Dietary Antioxidants and the Long-term Incidence of Age-Related Macular Degeneration
Tan, J. S. L., Wang, J. J., Flood, V., Rochtchina, E., Smith, W., & Mitchell, P. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2007.03.083 · Cited by 381
Butterfield, D. A., Poon, H. F., St. Clair, D., Keller, J. N., Pierce, W. M., Klein, J. B., & Markesbery, W. R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.11.002 · Cited by 377
A mouse model for X-linked adrenoleukodystrophy
Lu, J.-F., Lawler, A. M., Watkins, P. A., Powers, J. M., Moser, A. B., Moser, H. W., & Smith, K. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9366 · Cited by 293 · cited 1×
“The generation and genotyping of Abcd1 - mice has previously been described (39, 49, 50).”
Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders
Rodriguez, M. C., MacDonald, J. R., Mahoney, D. J., Parise, G., Beal, M. F., & Tarnopolsky, M. A. (2007) · Muscle & Nerve · doi:10.1002/mus.20688 · Cited by 255
Redox-Dependent Modulation of Aconitase Activity in Intact Mitochondria
Bulteau, A.-L., Ikeda-Saito, M., & Szweda, L. I. (2003) · Biochemistry · doi:10.1021/bi0353979 · Cited by 241
The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl–CoA esters
van Roermund, C. W. T., Visser, W. F., IJlst, L., van Cruchten, A., Boek, M., Kulik, W., Waterham, H. R., & Wanders, R. J. A. (2008) · The FASEB Journal · doi:10.1096/fj.08-110866 · Cited by 233 · cited 1×
“All patients have mutations in the gene encoding the ABCD1 protein (NM_000033), an ATP binding cassette peroxisomal transporter involved in the importing of very long-chain fatty acids (VLCFA, C ‡ 22:0) and VLCFA-CoA esters into the peroxisome for degradation (66).”
Pujol, A. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.499 · Cited by 214 · cited 2×
“The generation and genotyping of Abcd1 - mice has previously been described (39, 49, 50).”
Self-citationEarly oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy
Fourcade, S., Lopez-Erauskin, J., Galino, J., Duval, C., Naudi, A., Jove, M., Kemp, S., Villarroya, F., Ferrer, I., Pamplona, R., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn085 · Cited by 214 · cited 10×
“Earlier, we reported that the levels of lipoxidative (MDAL), glycoxidative/lipoxidative (CEL, CML), and protein oxidative (GSA; AASA) markers were about doubled in the fibroblasts derived from patients with X-ALD (20).”
InfluentialSelf-citationBaumgart, E., Vanhorebeek, I., Grabenbauer, M., Borgers, M., Declercq, P. E., Fahimi, H. D., & Baes, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62534-5 · Cited by 210
Pujol, A., Ferrer, I., Camps, C., Metzger, E., Hindelang, C., Callizot, N., Ruiz, M., Pàmpols, T., Giròs, M., & Mandel, J. L. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh323 · Cited by 201
Self-citationGeneral aspects and neuropathology of X-linked adrenoleukodystrophy
Ferrer, I., Aubourg, P., & Pujol, A. (2010) · Brain Pathology · doi:10.1111/j.1750-3639.2010.00390.x · Cited by 139 · cited 1×
“as a consequence of axonal degeneration in the spinal cord (17, 42).”
Self-citationFerrer, I., Kapfhammer, J. P., Hindelang, C., Kemp, S., Troffer-Charlier, N., Broccoli, V., Callyzot, N., Mooyer, P., Selhorst, J., Vreken, P., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi384 · Cited by 106 · cited 1×
“Evidence of ultrastructural anomalies of mitochondria in spinal neurons of Abcd1 - mice have been reported (18); this is consistent with previous findings of mitochondria alterations in liver of peroxisomal deficient models (5).”
Self-citationA key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis
Fourcade, S., Ruiz, M., Camps, C., Schlüter, A., Houten, S. M., Mooyer, P. A. W., Pàmpols, T., Dacremont, G., Wanders, R. J. A., Giròs, M., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90736.2008 · Cited by 104 · cited 1×
“Total RNA was extracted using RNeasy Kit (Qiagen), and Q-PCR experiments were performed according to manufacturer’s instructions (LightCycler, Roche Diagnostics) as previously described (21).”
Self-citationGilg, A. G., Singh, A. K., & Singh, I. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.12.1063 · Cited by 66
Research works printed but not linked: 51
- 10.1111/j.1582-4934.2008.00324.x · DOI · Paper page
- 10.1111/j.1471-4159.2009.05942.x · DOI · Paper page
- 10.1006/phrs.2000.0679 · DOI
- 10.1007/s10522-010-9301-8 · DOI
- 10.1016/j.bbadis.2010.06.006 · DOI
- 10.1016/j.nbd.2006.01.001 · DOI · Paper page
- 10.1111/j.1471-4159.2009.06397.x · DOI · Paper page
- 10.1089/ars.2009.3074 · DOI · Paper page
- 10.1007/s11064-010-0304-2 · DOI
- 10.1177/1533317508325093 · DOI · Paper page
- 10.1007/s11064-010-0295-z · DOI
- 10.1007/s10863-009-9243-5 · DOI · Paper page
- 10.1002/iub.352 · DOI
- 10.1093/hmg/ddq082 · DOI · Paper page
- 10.1016/j.bbadis.2009.08.010 · DOI · Paper page
- 10.1371/journal.pone.0005777 · DOI · Paper page
- 10.1016/B978-0-12-091302-2.50054-2 · doi:10.1016/b978-0-12-091302-2.50054-2
- 10.1016/S0014-5793(97)00029-X · DOI
- 10.1007/s11064-007-9466-y · DOI · Paper page
- 10.1016/j.neurobiolaging.2007.12.005 · DOI · Paper page
- 10.1038/ncb1881 · DOI · Paper page
- 10.1016/j.brainresrev.2009.10.003 · DOI · Paper page
- 10.1021/bi981512h · DOI · Paper page
- 10.1002/jcp.1041370102 · doi:10.1002/jcp.1041370102
- 10.1007/BF02705114 · DOI
- 10.1371/journal.pone.0006500 · DOI · Paper page
- 10.1089/ars.2007.1763 · DOI · Paper page
- 10.1038/nature05292 · DOI · Paper page
- López-Erauskin J Fourcade S Galino J Ruiz M Schlüter A Naudi A Jove M Portero-Otin M Pamplona R Ferrer I Pujol A. Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol (in press) DOI:10.1002/ana.22363 2011. · DOI · Paper page
- 10.1111/j.1750-3639.2009.00326.x · DOI · Paper page
- 10.3233/JAD-2007-12210 · DOI · Paper page
- 10.1074/jbc.M100320200 · DOI · Paper page
- 10.1016/S0891-5849(96)00269-9 · DOI · Paper page
- 10.1016/j.arr.2007.06.002 · DOI
- 10.1152/ajpcell.00232.2006 · DOI · Paper page
- 10.1002/jnr.22500 · DOI · Paper page
- 10.1111/j.1432-1033.1993.tb17638.x · DOI · Paper page
- 10.1177/1533317508325094 · DOI · Paper page
- 10.1073/pnas.0905529106 · DOI · Paper page
- 10.1006/abio.1998.2932 · DOI · Paper page
- 10.1081/DMR-100102336 · DOI · Paper page
- 10.1016/j.jns.2009.03.002 · DOI · Paper page
- 10.1111/j.1750-3639.2010.00392.x · DOI · Paper page
- 10.1016/j.arr.2008.07.003 · DOI
- 10.1523/JNEUROSCI.1899-04.2004 · DOI · Paper page
- 10.1074/jbc.M106798200 · DOI · Paper page
- 10.1016/j.addr.2008.05.001 · DOI
- 10.1523/JNEUROSCI.20-24-08972.2000 · DOI · Paper page
- 10.1098/rstb.2005.1764 · DOI · Paper page
- 10.1172/JCI34138 · DOI · Paper page
- 10.1016/j.abb.2009.03.001 · DOI
Cited by
X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects
Kemp, S., Berger, J., & Aubourg, P. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.012 · Cited by 283
“Research targeted at understanding the pathophysiology observed in the X-ALD mouse has resulted in novel therapeutic strategies that could potentially halt or slow down the neuroinflammation process and/or axonal degeneration [104].”
The peroxisome: an update on mysteries
Islinger, M., Grille, S., Fahimi, H. D., & Schrader, M. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-0941-4 · Cited by 281
X-Linked Adrenoleukodystrophy: Pathogenesis and Treatment
Engelen, M., Kemp, S., & Poll-The, B.-T. (2014) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0486-0 · Cited by 187
Peroxisomal ABC transporters: Structure, function and role in disease
Morita, M., & Imanaka, T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.02.009 · Cited by 183
López-Erauskin, J., Galino, J., Ruiz, M., Cuezva, J. M., Fabregat, I., Cacabelos, D., Boada, J., Martínez, J., Ferrer, I., Pamplona, R., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt186 · Cited by 125
Self-citation
Metadata
- Authors
- Galino, J., Ruiz, M., Fourcade, S., Schlüter, A., López-Erauskin, J., Guilera, C., Jove, M., Naudi, A., García-Arumí, E., Andreu, A. L., Starkov, A. A., Pamplona, R., Ferrer, I., Portero-Otin, M., & Pujol, A.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2011-10-15
- Volume
- 15
- Issue
- 8
- Pages
- 2095-2107
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W2033271062
- Cited by
- 85
- References
- 19
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.